Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-131828
Filing Date
2024-12-27
Accepted
2024-12-27 06:05:23
Documents
3
Period of Report
2024-12-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2432108d1_6k.htm 6-K 11413
2 EXHIBIT 99.1 tm2432108d1_ex99-1.htm EX-99.1 23364
3 GRAPHIC tm2432108d1_ex99-1img001.jpg GRAPHIC 2055
  Complete submission text file 0001104659-24-131828.txt   38974
Mailing Address INDUSTRIEPARK ZWIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052
Business Address INDUSTRIEPARK ZWIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052 32 (9) 310 34 00
ARGENX SE (Filer) CIK: 0001697862 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38097 | Film No.: 241582164
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)